ASTRID PHARMA
The most powerful lifestyle drug delivery system of our time.
OUR TECHNOLOGY
01 / MODULAR
We have engineered the viral capsid to package many molecules, from small to large biological molecules such as proteins and nucleic acids (DNA and RNA).
02 / APPLICABLE
Furthermore, the viral capsid’s surface can be engineered to allow targeted delivery to specific tissues and present multiple epitopes on the surface for vaccine purposes.
03 / RELIABLE
With relatively quick production time and cost, BioCapZ provides an easy-to-store nanoplatform using an icosahedral scaffold for a broad range of therapeutic and theranostic applications.
BioCapZ
Modular surface functionalization to carry targeting or tracking peptides, as well as immunogenic peptides for vaccine design.
We have engineered the viral capsid to package many molecules, from small to large biological molecules such as proteins and nucleic acids (DNA and RNA).
BioCapZ
BioCapZ BioCapZ is a protein-based nanoparticle that delivers nucleic acid cargo more effectively than AAVs, Lentivirus, and Polymer-based technologies.
Key benefits:
-
Able to target different tissues
-
Can be dosed orally, i.v, or s.c
-
High drug loading capacity for nucleic acids
-
Doesn't need refrigeration
The surface of BioCapZ comprises sixty repeating arms that can be decorated with targeting and tracking molecules, as well as immunogenic and therapeutic peptides.
Astrid Pharma Corp. is equipped with state-of-art high-yield production with a highly purified BioCapZ, reducing your cost and time to design and develop a functional capsule tailored to your experimental and commercial needs.
MEET BioCapZ
Proprietary BioCapZ™ platform based on hepatitis E viral capsid for noninvasive diagnostic and targeted therapeutic deliveries.
The BioCapZ technology was invented by Prof Holland Cheng based on the hepatitis E capsid. Prof Cheng’s laboratory has engineered the viral capsid to package a wide range of molecules from small molecules to large biological molecules as proteins and nucleic acids (DNA and RNA). Furthermore, the viral capsid’s surface can be engineered to allow targeted delivery to specific tissues as well as to present multiple epitopes on the surface for vaccine purposes